News | May 29, 2024
Lilly increases manufacturing investment to US$ 9 billion at newest Indiana site
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
Subscribe To Our Newsletter & Stay Updated
